Given the potential role of alcohol reduction in cardiovascular protection, we perform a mediation analysis of these pathways and coronary artery disease (CAD) risk to assess whether reductions in harmful alcohol consumption mediate the cardioprotective effects of GIPR/GLP1R agonism. Here, GLP1R is linked to coronary artery disorder.